Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors

Immune-mediated encephalitis as an adverse event due to checkpoint inhibitors is very rare. We describe herein the case of a 38-year-old woman with metastatic triple-negative breast cancer who developed seizures and somnolence twelve days after receiving the first dose of Atezolizumab. Work up ruled...

Descripción completa

Detalles Bibliográficos
Autores principales: Nader, Rita, Tannoury, Esther, Rizk, Tamina, Ghanem, Hady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital Universitário da Universidade de São Paulo 2021
Materias:
Clinical Case Report and Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087350/
https://www.ncbi.nlm.nih.gov/pubmed/33968830
http://dx.doi.org/10.4322/acr.2021.261

Ejemplares similares

Ejemplares similares